Blood Culture Tests Market Analysis

Analysis (Phenotypic AST, Genotypic AST)

The phenotypic AST segment in the blood culture tests market is anticipated to surpass USD 13.46 billion by the end of 2036. The growth of this segment is due to the increased demand for blood culture tests with a view to determining whether or not antibiotics are effective in preventing bacteria, thus providing physicians with vital information on appropriate antibiotic treatment options. The demand for phenotypic AST is also increasing due to an increased incidence of conditions such as sepsis. For example, sepsis is a potentially fatal disease that occurs when the body's response to an infection causes tissue and organ damage as defined by WHO. Although it is difficult to determine the true global epidemiological burden of sepsis, recent scientific papers estimate that an estimated 49 million people worldwide suffer from sepsis each year, and a total of 11 million people die from sepsis.

Test Type (Current Routine Test, Rapid Test)

Blood culture tests market from the current routine test segment is predicted to hold the largest growth rate of USD 12.10 billion by the end of the forecast period. One of the most important methods to monitor overall physical well-being is regular blood tests or a culture test. It may be able to understand the body changes over time and allow it to make informed decisions about health by being tested regularly. In order to diagnose infections and control the presence of germs in the blood, blood culture testing is commonly used.

Our in-depth analysis of the global blood culture tests market includes the following segments: